GDF2 and cancer: Thus, BMP9 might be an interesting quiescence factor in the context of vessel normalization but in this case, we might want to activate this pathway by giving recombinant BMP9 in cancer than rather blocking it and to combine it with current chemotherapies or immunotherapies.